Literature DB >> 12657724

Functional roles of hyaluronan in B16-F10 melanoma growth and experimental metastasis in mice.

Mark E Mummert1, Diana I Mummert, Lesa Ellinger, Akira Takashima.   

Abstract

Although hyaluronan (HA), a high molecular weight glycosaminoglycan, is generally believed to regulate tumor growth, invasion, and metastasis, functional roles of HA have only been speculated indirectly from the outcome of blocking HA receptors (e.g., CD44). Using a phage display technique, we recently developed a synthetic peptide (GAHWQFNALTVR; Pep-1) that binds to and inhibits the function of HA. In this study, we have used Pep-1 to determine whether HA directly regulates the behavior of tumor cells. B16-F10 melanoma cells, which constitutively expressed CD44, showed significant adhesion to HA-coated plates, and this adhesion was blocked almost completely either by neutralizing antibodies against CD44 or by Pep-1. These results imply that CD44 is the primary HA receptor mediating the adhesive interaction of the melanoma cells with HA substrates. In contrast, Pep-1 failed to inhibit in vitro proliferation of B16-F10 melanoma cells or the in vitro growth of the cells after s.c. inoculation in mice. Importantly, single injection of Pep-1 significantly reduced the incidence of lung metastasis of i.v. inoculated melanoma cells and prolonged the survival of the tumor-bearing animals. These results suggest a direct contribution of HA to one or more steps in the initial seeding of melanoma cells in the lung microenvironment. Our observations also introduce a new concept that synthetic inhibitors of HA may represent unique tools for studying the roles of HA in tumor biology and perhaps a new class of therapeutic reagents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657724

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  19 in total

1.  Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan.

Authors:  Aditya G Kohli; Saul Kivimäe; Matthew R Tiffany; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-20       Impact factor: 9.776

2.  Lymph node biophysical remodeling is associated with melanoma lymphatic drainage.

Authors:  Nathan Andrew Rohner; Jacob McClain; Sara Lydia Tuell; Alex Warner; Blair Smith; Youngho Yun; Abhinav Mohan; Manuela Sushnitha; Susan Napier Thomas
Journal:  FASEB J       Date:  2015-07-15       Impact factor: 5.191

3.  A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity.

Authors:  Alisson L Matsuo; Aparecida S Tanaka; Maria A Juliano; Elaine G Rodrigues; Luiz R Travassos
Journal:  J Mol Med (Berl)       Date:  2010-08-28       Impact factor: 4.599

Review 4.  Synthesis of self-assembled hyaluronan based nanoparticles and their applications in targeted imaging and therapy.

Authors:  Kunli Liu; Xuefei Huang
Journal:  Carbohydr Res       Date:  2022-01-05       Impact factor: 2.104

5.  A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.

Authors:  Cornelia Tolg; Sara R Hamilton; Ewa Zalinska; Lori McCulloch; Ripal Amin; Natalia Akentieva; Francoise Winnik; Rashmin Savani; Darius J Bagli; Len G Luyt; Mary K Cowman; Jim B McCarthy; Eva A Turley
Journal:  Am J Pathol       Date:  2012-08-11       Impact factor: 4.307

6.  Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase.

Authors:  Joshua I Park; Limin Cao; Virginia M Platt; Zhaohua Huang; Robert A Stull; Edward E Dy; Jeffrey J Sperinde; Jennifer S Yokoyama; Francis C Szoka
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

7.  Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell.

Authors:  Zhi Yao; Xu-Chun Che; Rong Lu; Min-Na Zheng; Zhi-Feng Zhu; Jin-Ping Li; Xu Jian; Lin-Xi Shi; Jun-Yan Liu; Wen-Yuan Gao
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

Review 8.  Hyaluronan as a therapeutic target in human diseases.

Authors:  Jiurong Liang; Dianhua Jiang; Paul W Noble
Journal:  Adv Drug Deliv Rev       Date:  2015-11-02       Impact factor: 15.470

9.  Identifying mRNA, microRNA and protein profiles of melanoma exosomes.

Authors:  Deyi Xiao; Joanna Ohlendorf; Yinlu Chen; Douglas D Taylor; Shesh N Rai; Sabine Waigel; Wolfgang Zacharias; Hongying Hao; Kelly M McMasters
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

10.  An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth.

Authors:  T Liu; A K Chopra
Journal:  Cancer Gene Ther       Date:  2009-08-28       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.